Barclays Maintains Overweight on Corteva, Raises Price Target to $91
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Barclays analyst Benjamin Theurer maintains Corteva (NYSE:CTVA) with a Overweight and raises the price target from $84 to $91.
Barclays analyst Benjamin Theurer maintains Corteva (NYSE:CTVA) with a Overweight and raises the price target from $84 to $91.